Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 291882011000036118 | agalsidase beta 35 mg injection, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 291884011000036110 | agalsidase beta 35 mg injection, 35 mg vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| agalsidase beta 35 mg injection, vial | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| agalsidase beta 35 mg injection, vial | Is a | agalsidase beta | true | Inferred relationship | Some | ||
| agalsidase beta 35 mg injection, vial | has intended active ingredient | agalsidase beta | true | Inferred relationship | Some | 1208382656 | |
| agalsidase beta 35 mg injection, vial | has Australian BoSS | agalsidase beta | true | Inferred relationship | Some | 1208382656 | |
| agalsidase beta 35 mg injection, vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| agalsidase beta 35 mg injection, vial | has unit of use | vial | true | Inferred relationship | Some | 1208382657 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Fabrazyme 35 mg powder for injection, 35 mg vial | Is a | True | agalsidase beta 35 mg injection, vial | Inferred relationship | Some | |
| agalsidase beta 35 mg injection, 1 vial | has MPUU | True | agalsidase beta 35 mg injection, vial | Inferred relationship | Some | 1 |
Reference Sets
List of Medicines for Brand Consideration reference set
Medicinal product unit of use reference set
FHIR